Annual report pursuant to Section 13 and 15(d)

Note 2 - Shareholders' Equity - Option Transaction Summary (Details)

v3.21.2
Note 2 - Shareholders' Equity - Option Transaction Summary (Details) - $ / shares
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Options, outstanding (in shares) 337,100 290,750
Weighted-average exercise price, outstanding (in dollars per share) $ 12.48 $ 11.86
Granted (in shares) 105,089 121,350
Weighted-average exercise price, Granted (in dollars per share) $ 23.74 $ 12.43
Weighted-average fair value, Granted (in dollars per share) $ 8.14 $ 4.62
Exercised (in shares) (101,966) (26,750)
Weighted-average exercise price, Exercised (in dollars per share) $ 12.47 $ 4.01
Forfeited and expired (in shares) (38,709) (48,250)
Weighted-average exercise price, Forfeited or Expired (in dollars per share) $ 13.68 $ 13.35
Options, outstanding (in shares) 301,514 337,100
Weighted-average exercise price, outstanding (in dollars per share) $ 16.25 $ 12.48